CLARANTIN

This brand name is authorized in Cyprus, Tunisia

Active ingredients

The drug CLARANTIN contains one active pharmaceutical ingredient (API):

1 Naftidrofuryl oxalate UNII 5ADB8D9388 - NAFRONYL OXALATE

Naftidrofuryl oxalate is a powerful vasodilator agent with an antagonist effect on 5-HT2 receptors of the smooth muscle cells. The vasodilator effect, which occurs in both the cerebral and peripheral circulation, is probably the main action. It is claimed that this action protects cells against the metabolic effects of ischaemia. Read about Naftidrofuryl

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CLARANTIN Hard capsule	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C04AX21	Naftidrofuryl	C Cardiovascular system → C04 Peripheral vasodilators → C04A Peripheral vasodilators → C04AX Other peripheral vasodilators
Discover more medicines within C04AX21

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6973023